Press Releases

Authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) builds on CAMP4’s recent clearances to initiate first-in-human studies for CMP-002 in Australia and Argentina Company anticipates initiation of the clinical trial in 4Q 2026 WATERTOWN, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the Company") (NASDAQ:CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the company has received authorization from the United

In the Past 5 Years Deako Has Shipped Over 32 million Units of Its Technologies Including Its Smart Home Plug-In Wall Switches, with Over $26M in Revenues in 2025  Deako is a Leading Technology Supplier to Over 50 U.S. Builders Including D.R. Horton, Toll Brothers, Risewell Homes, Adams Homes, Maronda Homes, Shea Homes, Schumacher Homes, Among Others, and is Expected to Fast Track SKYX’s Technologies to the Vast Builder Market Deako’s Lead Investor and Board Member, Include Paul Jacobs, former Chairman and CEO of Qualcomm, and Board Member Marwan Fawaz, former CEO of Nest SKYX and Deako Management will Hold a Conference Call Today, September 10, 2026, at 8:30 a.m. Eastern Time, to Discu

Current Visibility into Over $1.9 Billion of 2026 Investment VolumeImproved Outlook for 2026 Tenant Credit-Related Rent LossNEW YORK, Sept. 10, 2026 /PRNewswire/ -- W. P. Carey Inc. (W. P. Carey, NYSE: WPC), a leading net lease REIT specializing in corporate sale-leasebacks, build-to-suits and the acquisition of single-tenant net lease properties, today provided a business update regarding investment activity and its outlook for tenant credit-related rent loss.Investment Activity W. P. Carey currently has visibility into investment volume totaling more than $1.9 billion for full-year 2026, including approximately $1.4 billion of investment volume completed year to date, transactions in its p

Dani Reiss, Chair of the Board of Directors and Chief Executive Officer of Canada Goose Holdings Inc. (NYSE:GOOS, TSX:GOOS) ("Canada Goose"), is pleased to announce that on September 9, 2026, through DTR LLC ("DTR"), his investment holding company, he acquired an aggregate of 100,000 subordinate voting shares ("SVS") of Canada Goose through open market purchases on the Toronto Stock Exchange ("TSX") and other Canadian published markets.The acquisition increases Mr. Reiss’ ownership position in Canada Goose and reflects his continued long-term investment in the Company.Immediately prior to the acquisition reported hereby, Mr. Reiss beneficially owned and exercised control and direction over 1

Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology innovation, today announced that a poster evaluating botensilimab (BOT), an Fc-enhanced multifunctional anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, has been accepted for presentation at the International Gynecologic Cancer Society (IGCS) Annual Global Meeting, taking place October 1–3, 2026, in Montreal, Canada. The presentation will feature results from the recurrent ovarian cancer cohort of the large Phase 1b C-800-01 study, including patients with platinum-refractory/resistant disease, with analyses by platinum sensitivity status and long-term three-year overall survival. Presentation Detai

PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided, biotech/life sciences company focused on advancing novel and potentially disruptive therapeutic assets, today announced that an abridged Clinical Study Report (CSR) for SKNJCT-003 (NCT06608238) has been posted on ClinicalTrials.gov, providing transparent public access to the efficacy, safety, drug-delivery and clinical findings from the completed Phase 2 study.  Publication of the abridged CSR represents an important scientific milestone for SkinJect® and provides a transparent public record of the completed Phase 2 findings. The Company believes the dataset

Court Holds ATG Capital's Nomination Notice Valid and That Its Nominees Will Stand for Election at the October 14 Annual Meeting ATG Capital Streamlines Its Slate to Four Director Nominees to Ensure Independent Oversight Without Disrupting the Company's Operational Pivot Urges Stockholders to Vote "FOR" All Four ATG Capital Nominees on the Gold Proxy Card MIAMI, Sept. 10, 2026 (GLOBE NEWSWIRE) -- ATG Capital Management LP ("ATG Capital"), together with certain of its affiliates, the beneficial owner of approximately 16% of the outstanding shares of Empery Digital Inc. (NASDAQ:EMPD) ("Empery" or the "Company"), today commented on the August 28, 2026 ruling of the Delaware Court of Chance

MasterCraft Boat Holdings, Inc. (NASDAQ:MCFT) today announced financial results for its fiscal 2026 fourth quarter and year ended June 30, 2026. The overview, commentary, and results provided herein relate to our continuing operations, which consists of our Performance and Wake, Leisure, and Recreation and Sport Fishing segments. Performance and Wake was formerly reported as MasterCraft, Leisure was formerly reported as Pontoon, and Recreation and Sport Fishing was established following the combination with Marine Products Corporation ("Marine Products"), as discussed below. On May 15, 2026, the Company completed the merger with Marine Products ("Marine Products Transaction"). As a resu

- Expands on previously reported findings in which 84% of evaluable first-line PDAC patients treated with atebimetinib + mGnP maintained or gained weight at three months - - New analyses evaluate the overall survival implications of both preserving body mass and reducing tumor volume - NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ:IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced it will present a poster at the American Association for Cancer Research (AACR) Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development taking place September 25-28, 2026, in

NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the H.C. Wainwright 28th Annual Global Investment Conference, being held on September 14 - 16, 2026. The fireside chat is scheduled to take place on Monday, September 14, 2026, at 12:00pm ET. A live webcast of the fireside chat will be available on the Events page, located within the Investors & Media section, of the Company’s website at http://ir.tgtherapeutics.com/events. ABOUT TG THERAPEUTICSTG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition,

NEW YORK and TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (NASDAQ:HELP) (Cboe CA: HELP) (the "Company" or "Helus Pharma"), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists ("NSAs"), today announced that Michael Halstead, Helus Pharma’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City. The fireside chat will be webcast live on Wednesday, September 16, 2026 at 8:30 a.m. EDT. To register for the webcast, click here. A replay will be available on the Events & Presentations page of Helus Pharma’s investor relations website. A

PANAMA CITY, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Copa Holdings, S.A. (NYSE:CPA) today released preliminary passenger traffic statistics for August 2026: Copa Holdings (Consolidated)August2026August2025% ChangeASM (mm)(1)3,219.1 2,755.1 16.8% RPM (mm)(2)2,840.9 2,432.2 16.8% Load Factor(3)88.3% 88.3% —p.p.         Available seat miles - represents the aircraft seating capacity multiplied by the number of miles the seats are flown.Revenue passenger miles - represents the number of miles flown by revenue passengersLoad factor - represents the percentage of aircraft seating capacity that is utilized For August 2026, Copa Holdings' capacity (ASMs) increased by 16.8%, while system-wide passenge

GUANGZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2026. Recent Business Updates Therapy Selection & MRD OncoScreen® BCMatch Tissue Kit has officially entered the Priority Review Channel of the Center for Medical Device Evaluation (CMDE) under the NMPA.CanCatch Custom Kit and CanCatch Custom Kit (cPAS) have officially entered the Special Review Procedure for Innovative Medical Devices of CMDE under the NMPA.In August 2026, t

MasTec, Inc. (NYSE:MTZ) today announced the appointment of Ati Modak as Vice President of Investor Relations, effective September 2026. Mr. Modak joins MasTec from Goldman Sachs, where he served as Vice President, Equity Research, Energy Services, covering companies across the traditional and new energy sectors. Prior to joining Goldman Sachs in 2019, he worked at Citi. Mr. Modak received his Bachelor of Engineering degree from PDEU in India and his M.B.A. from Fordham University in New York. José Mas, MasTec's Chief Executive Officer, noted, "We are pleased to welcome Ati to MasTec family. He brings a unique combination of deep knowledge of the infrastructure services sector, familiari

Capital will support continued CNSide® commercial scale-up and development Initial tranche of funding provided at closing with future tranches linked to milestones Forecasted cash runway now into 2028 HOUSTON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (NASDAQ:CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform of precision diagnostics, targeted therapeutics, and artificial intelligence, today announced that it has entered into a financing agreement with 3i, LP ("3i Fund") for a senior secured facility of up to $20 million with royalty-based repayments. Under the agreement, the Company received initial funding at closing, with future tranc

SINGAPORE, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Concorde International Group (NASDAQ:CIGL) is pleased to announce its subsidiary, Concorde Security, as the Official Security Partner of Hougang United Football Club (HGFC) for the 2026/27 season. Through this partnership, Concorde Security will support the Club in providing a safe and welcoming matchday environment for supporters, families and the wider football community. Under the partnership, Concorde Security will support security operations at HGFC home matches in Singapore with trained security officers and marshals overseeing crowd management and access control. Its proprietary i-Facility Sprinter (IFS), a mobile command-and-control ve

BXP, Inc. (NYSE:BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that Owen Thomas – Chairman & CEO; Douglas Linde – President; and Michael LaBelle – Chief Financial Officer, will participate in and present at the BofA Securities 2026 Global Real Estate Conference, which will be held September 15-17, 2026, at Two Bryant Park Pavilion in New York City, New York. BXP expects to begin its presentation at approximately 3:45 PM ET on Tuesday, September 15, 2026. During the presentation, BXP executives may discuss the current operating environment, trends and strategies; development, redevelopment and other investment act

Newly Created Role Deepens Lazard's Equity Capital Markets Advisory Capabilities in North AmericaNEW YORK, Sept. 10, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE:LAZ) has announced that Daniel Burton-Morgan has joined the firm in a newly created role as a Managing Director and Head of Equity Capital Markets Advisory, North America, within the Strategic Capital Solutions Group, based in New York. The new role reflects Lazard's commitment to fully servicing clients across all of their capital markets needs. Daniel will play a central role in advising clients on equity capital markets strategy and execution, including initial public of

Redwood Trust, Inc. (NYSE:RWT, "Redwood" or the "Company")), a leader in expanding access to housing for homebuyers and renters, today announced that its Board of Directors (the "Board") has declared third quarter 2026 common and preferred stock dividends.Common Stock DividendThe Board has authorized the declaration of a third quarter 2026 regular common stock dividend of $0.18 per share, unchanged from the second quarter of 2026. This marks the Company's 109th consecutive quarterly common dividend. The third quarter 2026 common stock dividend is payable on September 30, 2026 to stockholders of record on September 23, 2026.Preferred Stock DividendIn accordance with the terms of Redwood’s 10.

ATLANTA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- PowerPlan, a leading provider of financial software solutions for asset-intensive companies, today announced Intelligent Unitization, the latest addition to a growing portfolio of asset intelligence offerings. Intelligent Unitization is the first AI-powered solution built specifically to support ongoing unitization and backlog reduction, a growing challenge for energy companies as they increase capital investments to meet today’s unprecedented demands. Unitization is the process of converting capital project costs into individual asset records once a project goes into service. As capital investments accelerate, the backlog grows: across the elec